The association between osteopontin and survival in non-small-cell lung cancer patients: a meta-analysis of 13 cohorts

References

• MountainCFRevisions in the international system for staging lung cancerChest19971116171017179187198
   PubMed Web of Science ®Google Scholar
• IshikawaMMiyaharaRSonobeMHigher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinomaLung Cancer201276343143822236865
   PubMed Web of Science ®Google Scholar
• DenhardtDTNodaMO’ReganAWPavlinDBermanJSOsteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survivalJ Clin Invest200110791055106111342566
   PubMed Web of Science ®Google Scholar
• ChuangCYChangHLinPUp-regulation of osteopontin expression by aryl hydrocarbon receptor via both ligand-dependent and ligand-independent pathways in lung cancerGene2012492126226922037483
   PubMed Web of Science ®Google Scholar
• ZhaoBSunTMengFOsteopontin as a potential biomarker of proliferation and invasiveness for lung cancerJ Cancer Res Clin Oncol201113771061107021207061
   PubMed Web of Science ®Google Scholar
• BoldriniLDonatiVDell’OmodarmeMPrognostic significance of osteopontin expression in early-stage non-small-cell lung cancerBr J Cancer200593445345716091764
   PubMed Web of Science ®Google Scholar
• DonatiVBoldriniLDell’OmodarmeMOsteopontin expression and prognostic significance in non-small cell lung cancerClin Cancer Res200511186459646516166420
   PubMed Web of Science ®Google Scholar
• WeberGFLettGSHaubeinNCOsteopontin is a marker for cancer aggressiveness and patient survivalBr J Cancer2010103686186920823889
   PubMed Web of Science ®Google Scholar
• HuZLinDYuanJOverexpression of osteopontin is associated with more aggressive phenotypes in human non-small cell lung cancerClin Cancer Res200511134646465216000556
   PubMed Web of Science ®Google Scholar
• SchneiderSYochimJBrabenderJOsteopontin but not osteonectin messenger RNA expression is a prognostic marker in curatively resected non-small cell lung cancerClin Cancer Res20041051588159615014008
   PubMed Web of Science ®Google Scholar
• ChangYSKimHJChangJAhnCMKimSKKimSKElevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancerLung Cancer200757337338017513004
   PubMed Web of Science ®Google Scholar
• IsaSKawaguchiTTeramukaiSSerum osteopontin levels are highly prognostic for survival in advanced non-small cell lung cancer: results from JMTO LC 0004J Thorac Oncol2009491104111019620934
   PubMed Web of Science ®Google Scholar
• TakenakaMHanagiriTShinoharaSSerum level of osteopontin as a prognostic factor in patients who underwent surgical resection for non-small-cell lung cancerClin Lung Cancer201314328829423122494
   PubMed Web of Science ®Google Scholar
• WellsGASheaBO’ConnellDThe Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analysesOttawa (ON)Ottawa Health Research Institute Available from: www.ohrica/programs/clinical_epidemiology/oxford.htmAccessed November 10, 2015
   Google Scholar
• ThompsonSGHigginsJPHow should meta-regression analyses be undertaken and interpreted?Stat Med200221111559157312111920
   PubMed Web of Science ®Google Scholar
• SongFGilbodySBias in meta-analysis detected by a simple, graphical test. Increase in studies of publication bias coincided with increasing use of meta-analysisBMJ199831671294719492690
   PubMed Web of Science ®Google Scholar
• SunBSLiYZhangZFYouJWangCLOsteopontin combined with CD44v6, a novel prognostic biomarker in non-small cell lung cancer undergoing curative resectionAnn Thorac Surg20139661943195124094519
   PubMed Web of Science ®Google Scholar
• ChambersAFWilsonSMKerkvlietNO’MalleyFPHarrisJFCassonAGOsteopontin expression in lung cancerLung Cancer19961533113238959677
   PubMed Web of Science ®Google Scholar
• RudAKBoyeKOijordsbakkenMOsteopontin is a prognostic biomarker in non-small cell lung cancerBMC Cancer20131354024215488
   PubMed Web of Science ®Google Scholar
• ZhangLHouXLuSPredictive significance of bone sialoprotein and osteopontin for bone metastases in resected Chinese non-small-cell lung cancer patients: a large cohort retrospective studyLung Cancer201067111411919376608
   PubMed Web of Science ®Google Scholar
• MackPCRedmanMWChanskyKSWOGLower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003J Clin Oncol200826294771477618779603
   PubMed Web of Science ®Google Scholar
• ZhangTZhangDMZhaoDHouXMYangTNOsteopontin expression is associated with platinum-based chemotherapy response and prognosis of patients with advanced non small cell lung cancerJ BUON201419374274825261661
   PubMed Web of Science ®Google Scholar
• HanSSLeeSJKimWJPlasma osteopontin is a useful diagnostic biomarker for advanced non-small cell lung cancerTuberc Respir Dis (Seoul)201375310411024101934
   PubMedGoogle Scholar
• OstheimerCBacheMGuttlerAKotzschMVordermarkDA pilot study on potential plasma hypoxia markers in the radiotherapy of non-small cell lung cancer. Osteopontin, carbonic anhydrase IX and vascular endothelial growth factorStrahlenther Onkol2014190327628224322994
   PubMed Web of Science ®Google Scholar
• YanCHLvMLiHOsteopontin is a novel prognostic biomarker in early-stage non-small cell lung cancer after surgical resectionJ Cancer Res Clin Oncol201514181371137825555465
   PubMed Web of Science ®Google Scholar
• EYHeNWangYFanHPercutaneous transluminal angioplasty (PTA) alone versus PTA with balloon-expandable stent placement for short-segment femoropopliteal artery disease: a metaanalysis of randomized trialsJ Vasc Interv Radiol200819449950318375292
   PubMed Web of Science ®Google Scholar
• KimJHSkatesSJUedeTOsteopontin as a potential diagnostic biomarker for ovarian cancerJAMA2002287131671167911926891
   PubMed Web of Science ®Google Scholar
• UeTYokozakiHKitadaiYCo-expression of osteopontin and CD44v9 in gastric cancerInt J Cancer19987921271329583725
   PubMed Web of Science ®Google Scholar
• FurgerKAMenonRKTuckABBramwellVHChambersAFThe functional and clinical roles of osteopontin in cancer and metastasisCurr Mol Med20011562163211899236
   PubMedGoogle Scholar
• YuTTHanZGShanLExpression of osteopontin in non-small cell lung cancer and correlative relation with microvascular densityAsian Pac J Cancer Prev2014151293224528042
   PubMedGoogle Scholar
• LeQTChenESalimAAn evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancersClin Cancer Res20061251507151416533775
   PubMed Web of Science ®Google Scholar
• FedarkoNSJainAKaradagAVan EmanMRFisherLWElevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancerClin Cancer Res20017124060406611751502
   PubMed Web of Science ®Google Scholar
• KarapanagiotouEMTerposEDilanaKDSerum bone turnover markers may be involved in the metastatic potential of lung cancer patientsMed Oncol201027233233819373566
   PubMed Web of Science ®Google Scholar
• OstheimerCBacheMGüttlerAReeseTVordermarkDPrognostic information of serial plasma osteopontin measurement in radiotherapy of non-small-cell lung cancerBMC Cancer20141485825416631
   PubMed Web of Science ®Google Scholar
• TrikalinosTASalantiGZintzarasEIoannidisJPMeta-analysis methodsAdv Genet20086031133418358326
   PubMed Web of Science ®Google Scholar